Zoetis, HABRI to promote human-animal bond research in new campaignMarch 10, 2017Having pets has been shown to improve human health. Which means veterinarians, in their roles as pet doctors, help improve human and public health too. That’s according to Zoetis, who, along with the Human Animal Bond Research Institute (HABRI) it is introducing a new campaign to promote a growing body of research that shows how important that bond is to human health, and how veterinary professionals are key contributors to human and health.
SPONSORED CONTENTYour Parasite Protection Recommendation, SimplifiedManaging parasite prevention doesn’t have to be complicated. Discover a single solution that protects against multiple threats. + Learn More
Zoetis announces recipient of equine charity sweepstakes donationMarch 7, 2017New Start, the Pennsylvania Horsemen's Benevolence and Protective Association (PA HBPA), was the recent recipient of a $5,000 donation from Zoetis’ Equine Charity Sweepstakes. The donation was received by the David Marshall, DVM, the veterinarian who nominated the New Start while attending the 2016 American Association of Equine Practitioners (AAEP) Annual Convention. He practices veterinary medicine at Penn National Race Course.
Zoetis receives FDA approval for heartworm disease treatmentFebruary 21, 2017Zoetis has announced that its heartworm treatment DIROBAN has received approval from the U.S. Food and Drug Administration (FDA). DIROBAN (melarsomine dihydrochloride) is for treatment of dogs infected with Dirofilaria omits — the cause of heartworm disease. It is now available for sale to veterinarians in the United States.
Personal Wellness gets Zoetis' attentionJanuary 18, 2017Zoetis Inc. has beefed up VetVance, the drug maker’s free, online career education platform, by adding seven videos addressing mental health issues as they relate to the veterinary field.
Zoetis earns license for Cytopoint skin therapyJanuary 4, 2017Veterinary drug maker Zoetis Inc. in December received a U.S. Department of Agriculture license for Cytopoint, which the Parsippany, N.J., company described as the first monoclonal antibody (mAb) therapy approved “to help provide sustained control of the clinical signs associated with atopic dermatitis in dogs.”
Zoetis: Lepto vaccine may be used with all maresDecember 30, 2016The equine leptospirosis vaccine Lepto EQ Innovator is now approved for use in broodmares during the entire pregnancy, manufacturer Zoetis Inc. reported.
Zoetis calls on vet students to apply for 2017 scholarshipsOctober 6, 2016Zoetis Inc., in partnership with the Association of American Veterinary Medical Colleges (AAVMC), is calling on second- and third-year veterinary students in the U.S. and Caribbean to apply for the 2017 Zoetis Veterinary Student Scholarship Award.
Diabetes Pet Care Alliance Program calls on vets to participate in programOctober 5, 2016November is National Diabetes Month, and the Diabetes Pet Care Alliance is once again encouraging veterinarians to enroll in their program.
Zoetis app helps monitor pet diabetesOctober 4, 2016Diabetic pets don’t carry smartphones, but they now have an app, PetDialog, made just for them. PetDialog and the revised AlphaTrak website make things easier for pet owners who need to manage their pet’s diabetes, according to the app’s developer, Zoetis Inc. of Florham Park, N.J.
Zoetis declares end to Apoquel shortageMay 23, 2016Apoquel, a highly praised anti-itch drug from Zoetis Inc., is readily available after the company resolved manufacturing issues that limited production.
